Synonyms: TFT | trifluorothymidine
trifluridine is an approved drug (Japan, FDA (2015), EMA (2016))
Compound class:
Synthetic organic
Comment: Trifluridine was originally approved by the US FDA in 1980, and was used for its antiviral effects (marketed as Vitroptic®). The drug is now being investigated for its antineoplastic (cytotoxic) effect.
|
|
References |
1. Tanaka N, Sakamoto K, Okabe H, Fujioka A, Yamamura K, Nakagawa F, Nagase H, Yokogawa T, Oguchi K, Ishida K et al.. (2014)
Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models. Oncol Rep, 32 (6): 2319-26. [PMID:25230742] |
2. Temmink OH, de Bruin M, Comijn EM, Fukushima M, Peters GJ. (2005)
Determinants of trifluorothymidine sensitivity and metabolism in colon and lung cancer cells. Anticancer Drugs, 16 (3): 285-92. [PMID:15711180] |